These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 29055361)

  • 1. The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.
    Pflugfelder SC; de Paiva CS
    Ophthalmology; 2017 Nov; 124(11S):S4-S13. PubMed ID: 29055361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GPR-68 in Human Corneal and Conjunctival Epithelium. Possible indicator and mediator of attrition associated inflammation at the ocular surface.
    van Setten GB
    J Fr Ophtalmol; 2023 Jan; 46(1):19-24. PubMed ID: 36503812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Response in Dry Eye.
    Yamaguchi T
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES192-DES199. PubMed ID: 30481826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TOPICAL ANTI-INFLAMMATORY AGENTS FOR DRY EYE DISEASE].
    Erdinest N; Solomon A
    Harefuah; 2019 Feb; 158(2):130-135. PubMed ID: 30779493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical cyclosporine A therapy for dry eye syndrome.
    de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
    Yang Y; Huang C; Lin X; Wu Y; Ouyang W; Tang L; Ye S; Wang Y; Li W; Zhang X; Liu Z
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3375-3384. PubMed ID: 30025085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.
    Chen YT; Li S; Nikulina K; Porco T; Gallup M; McNamara N
    Mol Vis; 2009; 15():563-76. PubMed ID: 19365590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
    Oh HN; Kim CE; Lee JH; Yang JW
    Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye.
    Julio G; Lluch S; Pujol P; Merindano MD
    Ophthalmic Physiol Opt; 2012 Jul; 32(4):317-23. PubMed ID: 22620852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
    Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
    Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
    Kim CE; Kleinman HK; Sosne G; Ousler GW; Kim K; Kang S; Yang J
    Sci Rep; 2018 Jul; 8(1):10500. PubMed ID: 30002412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery of the conjunctiva.
    Yokoi N; Inatomi T; Kinoshita S
    Dev Ophthalmol; 2008; 41():138-158. PubMed ID: 18453766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
    Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lacrimal film and the ocular surface].
    Creuzot-Garcher C
    J Fr Ophtalmol; 2006 Nov; 29(9):1053-9. PubMed ID: 17115000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin Inhibitor Voclosporin Preserves Corneal Barrier and Conjunctival Goblet Cells in Experimental Dry Eye.
    Alam J; de Souza RG; Yu Z; Stern ME; de Paiva CS; Pflugfelder SC
    J Ocul Pharmacol Ther; 2020 Nov; 36(9):679-685. PubMed ID: 32721249
    [No Abstract]   [Full Text] [Related]  

  • 19. Corneal collagen as a potential therapeutic target in dry eye disease.
    Baratta RO; Schlumpf E; Buono BJD; DeLorey S; Calkins DJ
    Surv Ophthalmol; 2022; 67(1):60-67. PubMed ID: 33882269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway.
    Zheng X; de Paiva CS; Li DQ; Farley WJ; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3083-91. PubMed ID: 20130281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.